Rehabilitación cardiaca, resucitación cardiopulmonar, valvulopatías... Bajo el epígrafe Miscelánea agrupamos algunas importantes sesiones de temática heterogénea que se celebraron en el Congreso 2008 de la European Society of Cardiology (ESC).
Peripheral Arterial Diseases
Mesa científica | Título | Ponente |
---|---|---|
Hot Line II | Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery. Results from a randomized placebo controlled trial: DECREASE III | Poldermans D (Rotterdam, NL) |
Hot Line II | Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery. Results from a randomized placebo controlled trial: DECREASE III - Discussant | Shelton M (Springfield, US) |
Rehabilitation and Exercise Physiology
Mesa científica | Título | Ponente |
---|---|---|
Moving from cure to palliation | No resuscitation orders - a challenge to include patients and family? | Lofmark R (Stockholm, SE) |
Sudden Cardiac Death and Resuscitation
Mesa científica | Título | Ponente |
---|---|---|
ESC Rene Laennec Lecture on Clinical Cardiology | Understanding sudden cardiac death: from the surface ECG to ion channels' genes | Schwartz P J (Pavia, IT) |
Thromboembolic Venous Disease
Mesa científica | Título | Ponente |
---|---|---|
Acute pulmonary embolism 2008 | Prognostic evaluation in pulmonary embolism | Galie N (Bologna, IT) |
Acute pulmonary embolism 2008 | Treatment options in pulmonary embolism | Konstantinides S V (Goettingen, DE) |
Acute pulmonary embolism 2008 | Long-term management after acute episode | Agnelli G (Perugia, IT) |
The new ESC guidelines | Pulmonary embolism | Torbicki A (Warsaw, PL) |
Valvular Heart Diseases
Mesa científica | Título | Ponente |
---|---|---|
Transcatheter valve therapy | Joint position of surgeons and cardiologists | Vahanian A (Paris, FR) |
Transcatheter valve therapy | Critical analysis of the results: mitral valve | Alfieri O (Milano, IT) |
Transcatheter valve therapy | Aortic valve | Mohr F W (Leipzig, DE) |
Transcatheter valve therapy | Appropriate training and environment | Maisano F (Milan, IT) |
Expanding horizons in mitral valve repair | Asymptomatic patients: crossing the guidelines or being in the forefront | Enriquez-Sarano M L (Rochester, US) |
Expanding horizons in mitral valve repair | Repair in patients with severe left ventricular dysfunction | Dion R (GENK, BE) |
Difficult management problems with aortic stenosis | Hypertension in aortic stenosis: impact on evaluation of stenosis severity | Pibarot P (Quebec, CA) |
Difficult management problems with aortic stenosis | Noncardiac surgery in asymptomatic aortic stenosis | Rosenhek R (Wien, AT) |
Difficult management problems with aortic stenosis | What is the best approach to coronary artery disease and moderate aortic stenosis? | Bermejo J (Madrid, ES) |
Percutaneous aortic valve implantation: a consensus between cardiologists and surgeons | Transfemoral aortic valve implantation | De Jaegere P P T (Rotterdam, NL) |
Percutaneous aortic valve implantation: a consensus between cardiologists and surgeons | Transapical aortic valve implantation | Walther T (Leipzig, DE) |
Percutaneous aortic valve implantation: a consensus between cardiologists and surgeons | What are the indications of percutaneous aortic valve implantation in 2008? | Nataf P (Paris, FR) |
Highlight Session | Valvular Heart Diseases | Baumgartner H (Muenster, DE) |
Endocarditis: diagnosis, decision making and treatment | Choice of valve and the rationale for valve sparing procedures | M Musci (Berlin, DE) |
Hot Line III | Simvastatin plus ezetimibe in aortic stenosis - The SEAS study | T R Pedersen (Oslo, NO) |
Hot Line III | Discussant | E Braunwald (Boston, US) |
Expanding horizons in mitral valve repair | Transcatheter approach | F Maisano (Milan, IT) |